Two doses of HPV-16/18 AS04-adjuvanted vaccine Cervarix are not inferior to three doses in the current schedule, a new study found. Since high coverage and compliance rates can be difficult to achieve with the current three-dose HPV vaccineregimen, several studies have looked at the possibility of reducing the number of doses. Proof-of-principle that a two-dose schedule can provide sufficient protection against cervical cancer came initially from a study performed ...
Read More
You have just read an article categorized health
titled Safety and Immunogenicity of 2 Doses of HPV-16/18 AS04 Adjuvanted Vaccine Revealed.
Written by:
editor -
Saturday, March 29, 2014
There are currently no comments for "Safety and Immunogenicity of 2 Doses of HPV-16/18 AS04 Adjuvanted Vaccine Revealed"
Post a Comment